Targeting N-RAS mutated tumours
30 Oct 2015
Targeting N-RAS mutated tumours
HVEM expression in melanoma metastasis: prognosis correlation
Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma
Tackling increasing prevalence of cancer and treatment costs
Cancer and the workplace
Preventing cancer in the EU through legislation, education and taxation
System reform needed for UK medicine approval
European Commission: Actions to tackle cancer
How should decision makers assess the value of a medicine?
Message to governments: Prevention is better than cure
Obesity and tobacco use increasing global cancer burden
Lessening the global financial burden of cancer